Product Program year 2021 Source: CMS Open Payments

HANAROSTENT LowAxTM Colon/Rectum(NNN)

Device EndoTherapy

PDI 008806367080899

Open in the dashboard

General payments

$209,617

210 payments

Research payments

$0

0 payments

Through program year 2021, $209,617 in general payments and $0 in research payments were reported against HANAROSTENT LowAxTM Colon/Rectum(NNN) (EndoTherapy).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2021 General $209,617 210

Breakdown

Who paid General payments · program year 2021
  1. Olympus Corporation of the Americas $191,394 21 payments
  2. Olympus America Inc. $18,222 189 payments
Top recipients General payments · program year 2021
  1. Mayo Clinic Hospital Teaching hospital · AZ $174,001 83% · 1 payment
  2. Muhammad Hasan Gastroenterology · Orlando, FL $9,533 5% · 8 payments
  3. James Tabibian Gastroenterology · Glendale, CA $4,354 2% · 6 payments
  4. Harry Aslanian Gastroenterology · New Haven, CT $3,998 2% · 3 payments
  5. David Lichtenstein Gastroenterology · Philadelphia, PA $3,690 2% · 4 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Gastroenterology Internal Medicine $25,980 95% · 86 practitioners
  2. Thoracic Surgery (Cardiothoracic Vascular Surgery) $230 <1% · 5 practitioners
  3. Pediatric Gastroenterology Pediatrics $149 <1% · 2 practitioners
  4. Nurse Practitioner, Acute Care Nurse Practitioner $149 <1% · 2 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $113 <1% · 7 practitioners

The top 5 of 20 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. Arizona $174,187 83% · 3 recipients
  2. Florida $11,704 6% · 6 recipients
  3. California $7,428 4% · 5 recipients
  4. Connecticut $3,998 2% · 1 recipient
  5. Massachusetts $3,701 2% · 2 recipients

The top 5 of 23 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

210 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record